Center on Health Equity & Access
Discover the latest research, insights, and news on health equity and access today!
Health Equity & Access Weekly Roundup: September 7, 2024
5 Underrecognized Social Determinants of Health
The Feasibility and Equity of Text Messaging to Determine Patient Eligibility for Lung Cancer Screening
Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization
Comprehensive Care: The Key to Managing Diabetes and Its Complexities
Dr Javed Butler Explains How Finerenone Is Shaping New Treatment Standards for HF
UPMC's Dr Manisha Jhamb Urges Better Kidney Disease Awareness, Integrated Care
Key Strategies Released for Integrating Equity Into Health Technology Assessment
When Is a Network Adequate? Consumer Perspectives on Network Adequacy Definitions
CMS Negotiated Drug Prices: Cardiologist's View on Affordability, Future Innovation
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Key Takeaways for Biosimilar Utilization
Promising Therapy Approaches for Advanced Friedreich Ataxia
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion
Key Applications, Challenges of Artificial Intelligence in Respiratory Care
Key Risk Factors for Interstitial Lung Disease in Rheumatic Diseases
Susan Sabo-Wagner Previews Key Themes of PCOC 2024
The Evolving Role for Pharmacists in Managed Care
Combatting the Opioid Epidemic With Dr Michael Lynch
Dr Sophia Humphreys Discusses GPO Impact on IDN, Hospital Product Decisions
The Feasibility and Equity of Text Messaging to Determine Patient Eligibility for Lung Cancer Screening
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
When Is a Network Adequate? Consumer Perspectives on Network Adequacy Definitions
Building a Virtual Model for Care After Cancer
Revised EOM Offers More Favorable Opportunities for Community Practices, Experts Say
Collaborative Innovation: Flatiron Health and Canopy Partner to Streamline Continuous Care for Oncology Practices
Geographic Variability of Medicaid Acceptance Among Allergists in the US
The Accelerated Approval Program for Oncology Drugs: Celebrating More Than 250,000 Life-Years Gained and Counting
A Machine Learning Technology for Addressing Medication-Related Risk in Older, Multimorbid Patients
Using NLP to Find “Hidden” Patients for Clinical Trials
Integrating Guideline-Driven Protocols Into Evidence-Based Practice to Improve Outcomes in Patients With Pulmonary Arterial Hypertension
AJMC® Powered by Patients and Managed Care Insights – More Than a Cosmetic Disease: Vitiligo Treatment Approaches and Raising Awareness of the Disease Burden
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
